Search Results - "FILIPPONI, P"

Refine Results
  1. 1

    Physical and mechanical properties of cement-based products containing incineration bottom ash by Filipponi, P, Polettini, A, Pomi, R, Sirini, P

    Published in Waste management (Elmsford) (2003)
    “…This paper presents the results of a wider experimental programme conducted in the framework of the NNAPICS (“Neural Network Analysis for Prediction of…”
    Get full text
    Journal Article
  2. 2

    Quantitative heel ultrasound in a population-based study in Italy and its relationship with fracture history: the ESOPO study by Maggi, S, Noale, M, Giannini, S, Adami, S, Defeo, D, Isaia, G, Sinigaglia, L, Filipponi, P, Crepaldi, G

    Published in Osteoporosis international (01-02-2006)
    “…We assessed the clinical usefulness of quantitative ultrasound (QUS) in defining the prevalence rates of osteoporosis and osteopenia and their association with…”
    Get full text
    Journal Article
  3. 3

    Bone mineral density in patients with psoriatic arthritis by FREDIANI, Bruno, ALLEGRI, Alessandra, FALSETTI, Paolo, STORRI, Lara, BISOGNO, Stefania, BALDI, Fabio, FILIPPONI, Paolo, MARCOLONGO, Roberto

    Published in Journal of rheumatology (01-01-2001)
    “…OBJECTIVE: Little information is available concerning bone mass in patients with psoriatic arthritis (PsA): the existence of less severe periarticular…”
    Get full text
    Journal Article
  4. 4

    The effect of age, weight, and lifestyle factors on calcaneal quantitative ultrasound: the ESOPO study by ADAMI, Silvano, GIANNINI, Sandro, GIORGINO, Ruben, ISAIA, Giancarlo, MAGGI, Stefania, SINIGAGLIA, Luigi, FILIPPONI, Paolo, CREPALDI, Gaetano, DI MUNNO, Ombretta

    Published in Osteoporosis international (01-03-2003)
    “…Quantitative ultrasound (QUS) techniques have been shown to be as good as bone mineral density (BMD) assessed by dual-energy X-ray absorptiometry (DXA), in…”
    Get full text
    Journal Article
  5. 5

    Guidelines for the diagnosis, prevention and treatment of osteoporosis by Adami, S, Bertoldo, F, Brandi, M L, Cepollaro, C, Filipponi, P, Fiore, E, Frediani, B, Giannini, S, Gonnelli, S, Isaia, G C, Luisetto, G, Mannarino, E, Marcocci, C, Masi, L, Mereu, C, Migliaccio, S, Minisola, S, Nuti, R, Rini, G, Rossini, M, Varenna, M, Ventura, L, Bianchi, G

    Published in Reumatismo (01-10-2009)
    “…The guidelines for the osteoporosis management were first drafted by a working group and then critically evaluated by the board of SIOMMMS. The most relevant…”
    Get full text
    Journal Article
  6. 6

    Effect of age, weight and lifestyle factors on calcaneal quantitative ultrasound in premenopausal women: the ESOPO study by Adami, S, Giannini, S, Giorgino, R, Isaia, G C, Maggi, S, Sinigaglia, L, Filipponi, P, Crepaldi, G

    Published in Calcified tissue international (01-04-2004)
    “…The objective of this study was to identify the determinants of bone mass as measured by quantitative ultrasound (QUS) in premenopausal women. The study…”
    Get full text
    Journal Article
  7. 7

    Association of quantitative heel ultrasound with history of osteoporotic fractures in elderly men : The ESOPO study by VARENNA, M, SINIGAGLIA, L, CREPALDI, G, ADAMI, S, GIANNINI, S, ISAIA, G, MAGGI, S, FILIPPONI, P, DI MUNNO, O, MAUGERI, D, DE FEO, D

    Published in Osteoporosis international (01-12-2005)
    “…In order to evaluate the usefulness of calcaneal quantitative ultrasound (QUS) in the assessment of male osteoporosis, a cross-sectional, population-based…”
    Get full text
    Journal Article
  8. 8

    Short-term intravenous therapy with Neridronate in Paget's disease by ADAMI, S, BEVILACQUA, M, BROGGINI, M, FILIPPONI, P, ORTOLANI, S, PALUMMERI, E, ULIVIERI, F, NANNIPIERI, F, BRAGA, V

    “…To describe the effects of two consecutive intravenous infusions of aminohexane bisphosphonate (Neridronate) in patients with active Paget's disease of bone…”
    Get full text
    Journal Article
  9. 9

    Bone mineral density in patients with systemic sclerosis by Frediani, B, Baldi, F, Falsetti, P, Acciai, C, Filippou, G, Spreafico, A, Chellini, F, Capperucci, C, Filipponi, P, Galeazzi, M, Marcolongo, R

    Published in Annals of the rheumatic diseases (01-03-2004)
    “…A previous study reported that bone mass was related to the extent of skin involvement but did not evaluate the extent of visceral involvement. 5 Many authors…”
    Get full text
    Journal Article
  10. 10

    Clinical determinants of bone mass and bone ultrasonometry in patients with systemic sclerosis by FREDIANI, B, BALDI, F, GALEAZZI, M, MARCOLONGO, R, FALSETTI, P, ACCIAI, C, FILIPPOU, G, SPREAFICO, A, SIAGRI, C, CHELLINI, F, CAPPERUCCI, C, FILIPPONI, P

    Published in Clinical and experimental rheumatology (01-05-2004)
    “…The aim of this study was to evaluate bone mass and bone ultrasonometry in patients affected with systemic sclerosis (SSc). Fifty-five patients (mean age 54.1…”
    Get full text
    Journal Article
  11. 11

    Poorly controlled elderly Type 2 diabetic patients: the effects of increasing sulphonylurea dosages or adding metformin by Gregorio, F., Ambrosi, F., Manfrini, S., Velussi, M., Carle, F., Testa, R., Merante, D., Filipponi, P.

    Published in Diabetic medicine (01-12-1999)
    “…Summary Aims To assess the effects and safety of increasing sulphonylurea dosages or adding metformin in poorly controlled elderly Type 2 diabetic patients…”
    Get full text
    Journal Article
  12. 12

    Osteopenia associated with non-insulin-dependent diabetes mellitus: what are the causes? by Gregorio, F, Cristallini, S, Santeusanio, F, Filipponi, P, Fumelli, P

    Published in Diabetes research and clinical practice (01-02-1994)
    “…This study investigated whether alterations in bone mineral content (BMC) and/or in the phosphate-calcium metabolism exist in non-insulin-dependent diabetes…”
    Get more information
    Journal Article
  13. 13

    Italian guidelines for the diagnosis and treatment of Paget's disease of bone by Adami, S, Bartolozzi, P, Brandi, M L, Falchetti, A, Filipponi, P, Gonnelli, S, Bianchi, G, Isaia, G C, Nuti, R

    Published in Reumatismo (01-04-2007)
    “…Paget's disease of bone is a chronic focal abnormality of bone turnover that remains totally asymptomatic over a very long period of time but that eventually…”
    Get full text
    Journal Article
  14. 14

    Paget’s disease of bone: benefits of neridronate as a first treatment and in cases of relapse after clodronate by Filipponi, P, Cristallini, S, Policani, G, Casciari, C, Gregorio, F

    Published in Bone (New York, N.Y.) (01-12-1998)
    “…This study assessed the efficacy of 200 mg of aminohexane bisphosphonate (neridronate) administered by intravenous infusion in a single dose or in two separate…”
    Get full text
    Journal Article
  15. 15

    Cyclical intravenous clodronate in postmenopausal osteoporosis: Results of a long-term Clinical trial by Filipponi, P., Cristallini, S., Rizzello, E., Policani, G., Fedeli, L., Gregorio, F., Boldrini, S., Troiani, S., Massoni, C.

    Published in Bone (New York, N.Y.) (01-02-1996)
    “…We report the results of long-term cyclical clodronate therapy (200 mg IV infusion every 3 weeks) on 235 women with postmenopausal osteoporosis recruited over…”
    Get full text
    Journal Article
  16. 16

    Intermittent versus continuous clodronate administration in postmenopausal women with low bone mass by Filipponi, P, Cristallini, S, Policani, G, Schifini, M.F, Casciari, C, Garinei, P

    Published in Bone (New York, N.Y.) (01-03-2000)
    “…The aim of the study was to compare the effects on bone mass and turnover of continuous vs. intermittent clodronate administration on 120 postmenopausal women…”
    Get full text
    Journal Article
  17. 17

    Therapeutical concentrations of tolbutamide, glibenclamide, gliclazide and gliquidone at different glucose levels: in vitro effects on pancreatic A- and B-cell function by Gregorio, F, Ambrosi, F, Cristallini, S, Pedetti, M, Filipponi, P, Santeusanio, F

    Published in Diabetes research and clinical practice (01-12-1992)
    “…In the classical model of isolated perfused rat pancreas four commonly used sulfonylureas--tolbutamide, glibenclamide, gliquidone and gliclazide--were…”
    Get more information
    Journal Article
  18. 18

    Meformin, plasma glucose and free fatty acids in type II diabetic out-patients: results of a clinical study by Gregorio, F, Ambrosi, F, Manfrini, S, Santucci, A, Filipponi, P

    Published in Diabetes research and clinical practice (01-07-1997)
    “…Abnormalities in free fatty acid (FFA) metabolism are an intrinsic feature of type II diabetes mellitus and may even play a role in the development of…”
    Get full text
    Journal Article
  19. 19

    Is metformin safe enough for ageing type 2 diabetic patients? by Gregorio, F, Ambrosi, F, Filipponi, P, Manfrini, S, Testa, I

    Published in Diabetes & metabolism (01-02-1996)
    “…We assessed the effect of adding low doses of metformin to sulfonylurea therapy in 76 elderly Type 2 diabetic patients by monitoring glycaemic control and…”
    Get more information
    Journal Article
  20. 20

    Effects of two different bisphosphonates on Paget's disease of bone: ICTP assessed by Filipponi, P, Pedetti, M, Beghe, F, Giovagnini, B, Miam, M, Cristallini, S

    Published in Bone (New York, N.Y.) (01-05-1994)
    “…Clodronate and alendronate were compared in 27 patients with active Paget's bone disease. Carboxyterminal crosslinked telopeptide of type I collagen (ICTP) was…”
    Get more information
    Journal Article